J9061 Injection, amivantamab-vmjw
J-Codes
Also known as: amivantamab, Rybrevant
Intravenous injection of amivantamab-vmjw, a bispecific monoclonal antibody targeting epidermal growth factor receptor (EGFR) and MET.
Clinical Context
Used to treat EGFR exon 20 insertion-mutated non-small cell lung cancer, blocking both EGFR and MET signaling.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.